Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

European Urological Device Market Will Be Driven By Adoption Of New Minimally Invasive Devices

August 1, 2013 8:00 am | by PR Newswire | News | Comments

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, patient and hospital demand for minimally invasive and discreet devices is rising within European markets for urological devices, and products that meet these needs are poised to see strong adoption through 2021.

Tiny, Brightly Shining Silicon Crystals Could Be Safe for Deep-Tissue Imaging

July 31, 2013 12:14 pm | by Charlotte Hsu, University at Buffalo | News | Comments

Tiny silicon crystals caused no health problems in monkeys three months after large doses were injected, marking a step forward in the quest to bring such materials into clinics as biomedical imaging agents, according to a new study. The findings suggest that the silicon nanocrystals, known as quantum dots, may be a safe tool for diagnostic imaging in humans.

Chemists Develop Innovative Nano-Sensors for Multiple Proteins

July 31, 2013 12:07 pm | by Universität Mainz | News | Comments

Chemists at Johannes Gutenberg University Mainz (JGU) have developed a new method for parallel protein analysis that is, in principle, capable of identifying hundreds or even thousands of different proteins. It could be used to detect the presence of viruses and identify their type in tiny samples.

Advertisement

A Spectrometer for the Future

July 31, 2013 10:25 am | by Eric Gershon, Yale University | News | Comments

Taking advantage of the sensitive nature of randomly scattered light, Yale University researchers have developed an ultra-compact, low-cost spectrometer with improved resolution over existing micro models. The innovation represents an advance in “lab-on-a-chip” technology, or the consolidation of laboratory capabilities in miniature, highly portable devices.

Panel Backs Lung Cancer Screening for Some Smokers

July 30, 2013 12:54 pm | by Marilynn Marchione, AP Chief Medical Writer | News | Comments

For the first time, government advisers are recommending screening for lung cancer, saying certain current and former heavy smokers should get annual scans to cut their chances of dying of the disease. If it becomes final as expected, the advice by the U.S. Preventive Services Task Force would clear the way for insurers to cover CT scans, a type of X-ray, for those at greatest risk.

Pushing Microscopy Beyond Standard Limits

July 30, 2013 9:38 am | by Caltech | News | Comments

Engineers at the California Institute of Technology (Caltech) have devised a method to convert a relatively inexpensive conventional microscope into a billion-pixel imaging system that significantly outperforms the best available standard microscope.

GE Healthcare Submits the Final Module of Its Premarket Approval Application (PMA) for GE Breast Tomosynthesis Option

July 30, 2013 9:00 am | by Business Wire | News | Comments

GE Healthcare, a unit of General Electric Company (NYSE:GE), announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the final module of its premarket approval application (PMA1) for GE Breast Tomosynthesis, an option of the Senographe Essential system.

PTS, Inc. Introduces CardioChek® Plus Analyzer

July 30, 2013 6:00 am | by PR Newswire | News | Comments

Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of the CardioChek family of point-of-care diagnostic products, introduced the CardioChek Plus analyzer today at the annual American Association for Clinical Chemistry (AACC) in Houston. 

Advertisement

IntelligentMDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay

July 29, 2013 4:41 pm | by PR Newswire | News | Comments

IntelligentMDx (privately held) announced today that the U.S. Food and Drug Administration (FDA) has cleared its automated molecular diagnostic test that detects the presence of vanA and vanB genes that can be associated with vancomycin-resistant enterococci (VRE).

University Researches Effectiveness of Telehealth

July 29, 2013 11:27 am | by University of Salford | News | Comments

The University of Salford has carried out a systematic review of the literature to research the effectiveness of telehealth on clinical outcomes, cost effectiveness and patient experience. Telehealth allows patients to monitor long-term health conditions from home, reducing visits to a clinic or hospital.

Bringing Wi-Fi to Healthcare

July 29, 2013 10:54 am | by Joe Zeto, Director of Product Marketing for Ixia | Articles | Comments

Today’s medical staffs increasingly rely upon wireless networks and devices to conduct critical-care applications, access electronic medical records and test results, and to share information throughout facilities. At the same time, Wi-Fi networks in healthcare facilities are being pushed to the limits by the Bring Your Own Device (BYOD) trend among patients and guests.

Breakthrough in Detecting DNA Mutations Could Help Treat Tuberculosis, Cancer

July 29, 2013 10:24 am | by University of Washington | News | Comments

Modern genomics has shown that just one mutation can be the difference between successfully treating a disease and having it spread rampantly throughout the body. Now, researchers have developed a new method that can look at a specific segment of DNA and pinpoint a single mutation, which could help diagnose and treat diseases such as cancer and tuberculosis.

RainDrop System Unlocks Power of Trovagene's Urine-Based Mutation Detection Technology

July 29, 2013 5:00 am | by PR Newswire | News | Comments

Trovagene, Inc. (NASDAQ: TROV) and RainDance Technologies announced today that Trovagene has adopted RainDance's RainDropTM Digital PCR System for research and development, and for eventual use in the Trovagene CLIA laboratory.  Trovagene has also announced successful development of a cell-free DNA mutation assay leveraging the RainDrop platform.

Advertisement

Cepheid Receives FDA Market Authorization for Xpert MTB/RIF

July 26, 2013 11:45 am | by Cepheid | News | Comments

Cepheid has announced that it has received market authorization from the U.S. Food & Drug Administration (FDA) for its Xpert MTB/RIF test. The review decision was based on the de novo 510(k) review process, which allows novel products without predicates to be down-classified and brought to market.

Cepheid Receives FDA Market Authorization for Xpert MTB/RIF

July 25, 2013 5:29 pm | by PR Newswire | News | Comments

Cepheid today announced it has received market authorization from the U.S. Food & Drug Administration (FDA) for its Xpert MTB/RIF test. The review decision was based on the de novo 510(k) review process, which allows novel products without predicates to be down-classified and brought to market.

Study in British Journal of Urology International Features a Practical Solution for MRI-Ultrasound Fusion to Enable Tumor-Targeted, Tissue-Preserving Prostate HIFU Treatment

July 25, 2013 2:16 pm | by The Associated Press | News | Comments

Study results published in the current issue of British Journal of Urology International (10.1111/bju.12223) demonstrate that new software to register and fuse information from magnetic resonance imaging (MRI) and ultrasound (US) images enables intraoperative visualization of tumors, not ordinarily seen in a US image.

A Promising Test for Pancreatic Cancer ... From a Teenager

July 25, 2013 10:12 am | Videos | Comments

Over 85 percent of all pancreatic cancers are diagnosed late, when someone has less than two percent chance of survival. How could this be? Jack Andraka talks about how he developed a promising early detection test for pancreatic cancer that’s super cheap, effective and non-invasive -- all before his 16th birthday.

A Quick Test for the Black Death

July 24, 2013 11:54 am | by Max-Planck-Gesellschaft | News | Comments

Diagnosing the presence of Yersinia pestis, the cause of plague, may soon be easier than ever before. Scientists working with Peter Seeberger, Director at the Max Planck Institute of Colloids and Interfaces (MPIKG) in Potsdam and Professor at the Freie Universität Berlin, have come up with a simple, inexpensive and reliable method of detecting the bacterium.

‘Standards’ for Home Healthcare

July 23, 2013 4:44 pm | by Todd Konieczny, Assistant Chief Engineer, Americas Region; Technical Manager, Medical Division, Intertek | Blogs | Comments

The following standard must be met for all medical products intended to be used in the home: IEC 60601-1-11, which is “Medical Electrical Equipment—Part 1-11: General Requirements for Basic Safety and Essential Performance—Collateral Standard: Requirements for Medical Electrical Equipment and Medical Electrical Systems Used in the Home Healthcare Environment.”

Controlling Genes with Light

July 23, 2013 11:22 am | by Anne Trafton, MIT News Office | News | Comments

Although human cells have an estimated 20,000 genes, only a fraction of those are turned on at any given time, depending on the cell’s needs — which can change by the minute or hour. To find out what those genes are doing, researchers need tools that can manipulate their status on similarly short timescales.

The healthcare IT applications of Google Glass

July 23, 2013 8:29 am | by Mass Device | News | Comments

Last week I had the opportunity to test Google Glass. It's basically an Android smartphone (without the cellular transmitter) capable of running Android apps, built into a pair of glasses. The small prism "screen" displays video at half HD resolution.

Zynex Signs Strategic Agreement With Advanced Brain Monitoring, Expands Presence in Sleep Diagnostic Market

July 22, 2013 8:00 am | by The Associated Press | News | Comments

Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnostics and cardiac monitoring, announces that it signed a strategic sales, marketing and distribution agreement with California based Advanced Brain Monitoring.

Urine-based Cancer Detection Technology Validated

July 22, 2013 5:00 am | by The Associated Press | News | Comments

Trovagene, Inc. announces that results emerging from ongoing clinical studies have confirmed the broad applicability of Trovagene technology across a variety of cancer types, and the successful development of a molecular diagnostic test capable of detecting and quantifying oncogene mutations from a simple urine specimen.

The Search for the Best Depression Treatment

July 22, 2013 12:00 am | by Massachusetts Institute of Technology | News | Comments

When someone is diagnosed with depression, patient and doctor often begin a long trial-and-error of different treatments. Sometimes they work, sometimes they don’t, so patients may try several options before finding the best one. But in the future, a brain scan, blood test, or some combination could help guide doctors to the best drugs, or lead them to suggest talk therapy.

Gamma Medica closes $18M Series A round | Wall Street Beat

July 19, 2013 1:56 pm | by Mass Device | News | Comments

Gamma Medica said it's closed a $16 million Series A round from Psilos Group Managers. The Northridge, Calif.-based company said it plans to use the cash to expand the commercial footprint of its LumaGen molecular breast imaging device and the LumaGuide biopsy model.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading